Love to see more collabs & transparency! NIIMBL Invests $15.8M into 14 New #biopharma manufacturing Projects w/ suppliers like @PallBiotech, Sartorius, Merck, & more via APR: americanpharmaceuticalreview.com/1315-News/5890…

Even with shifting interest, small molecules are still a large part of the market. But is quality getting compromised along the way? And... What Goes Wrong When API #Quality is Compromised? pharmtech.com/view/what-goes… via kathy waybrant

Reflections on the History of #GeneTherapy #Development summarized so well by Dave Backer OxfordBiomedica via BioProcess Intl.: shar.es/afsimR

LOUDER FOR THE PEOPLE IN THE BACK. The underdone stuff might take longer to lay the foundation for, but it returns for life if done well.

Where is the concept of continuous processing for #Viral Vectors? Challenges & potential from industry leaders Charles River Labs, @Polyplus_Bio, @PallBiotech, Repligen, & ViroCell in BioPharm Intl: biopharminternational.com/view/continuou… via Spectroscopy Magazine

OSTP Issues Guidance to Make Federally Funded Research Freely Available Without Delay whitehouse.gov/ostp/news-upda… via The White House

Deciding Where to #Outsource in #Biopharma Development and #Manufacturing featuring some of my own faves, Center for Breakthrough Medicines & Exothera: biopharminternational.com/view/deciding-… via Spectroscopy Magazine BioPharm Intl

AI Detects Early #ParkinsonsDisease from Breathing Patterns insideprecisionmedicine.com/topics/patient… via @clinicalomics

We have an amazing team of editors at Nature Chemistry and I’m excited to add to it! I need someone to take some of my manuscripts off my hands so I can do some ‘Chiefing’.

Just when the world feels a little too heavy, this... As #Philly becomes a hub for #lifesciences, a new program will train workers for jobs in the field: inquirer.com/business/drugs… via The Philadelphia Inquirer

Good to see on the FACT SHEET: President Biden to Launch a National #Biotechnology and #Biomanufacturing Initiative whitehouse.gov/briefing-room/… via The White House

A million times over, THANK YOU, ISCT! People tried to sell my family stem cell "therapies" for my dad when he had #Parkinsons. Thankfully I knew better, but many people do not. The SVF stuff is equally terrifying as an "over the counter". These things need to be regulated!

Making a complex topic relatable, Anna Rose Welch Cell&Gene: What Violin Making Can Teach Us About #mRNA Therapeutic #Quality: cellandgenecollaborative.com/doc/what-violi…

Great piece posting from the ISCT event in SF. #Collaboration & relationship building key to finding answers to CGT challenges with insight from Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉, too: biopharma-reporter.com/Article/2022/0… via BioPharma-Reporter

Happening now! One of my favorite speakers, Tania Pereira Chilima from Univercells Technologies (⁦an ⁦Gamma Biosciences⁩ company) on flexible integration at #bpiconf:

Closing the #bpiconf out w/ a state of the industry talk w/ Dan Stanton & industry leaders from Sartorius, Avid Bioservices & Latham Biopharm Group.

CDMO M&A: What Are The Important Moves? via DCAT Value Chain Insights: dcatvci.org/features/cdmo-…

What an amazing night last night with so many people I respect & enjoy & always learn from. Great job, ⁦Alliance for Regenerative Medicine (ARM)⁩. Fabulous show so far!

And so it begins... I think you're going to see a lot of this coming up. There's a lot of players building a lot of capacity. It's just too thick... Corium sells off CDMO business for $400m outsourcing-pharma.com/Article/2022/1…